Literature DB >> 9361010

Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.

T Soucek1, O Pusch, R Wienecke, J E DeClue, M Hengstschläger.   

Abstract

Tuberous sclerosis is an autosomal dominant disorder characterized by the development of benign growths in many tissues and organs. Linkage analysis revealed two disease-determining genes on chromosome 9 and chromosome 16. The TSC2 gene on chromosome 16 encodes a 1784-amino acid tumor suppressor protein, tuberin, that functions as a GTPase-activating protein for Rap1, a member of the superfamily of Ras-related proteins. By immunoblot analyses, we found TSC2 expression to be high in G0 as well as in early small G1 cells. Analyses after different cell synchronization procedures revealed that TSC2 mRNA and protein expression do not fluctuate throughout the cell cycle. Using inducible expression systems we further demonstrated that TSC2 expression is not affected by overexpression of the mitogenic transcription factor E2F-1 or c-Myc. Nevertheless, antisense inhibition of tuberin expression in logarithmically growing cells markedly decreased the percentage of cells in G1. Furthermore, we found that cells exposed to TSC2 antisense oligonucleotides did not undergo G0 arrest after serum withdrawal. Antisense inhibition of TSC2 expression also induced quiescent G0-arrested fibroblasts to reenter the cell cycle. Our data show for the first time that the absence of tuberin can both induce cells to pass through the G1/S transition of the eukaryotic cell cycle and prevent them from entering a quiescent state. These results have clear implications for the tumor suppressor function of TSC2. We further found that reentry into the cell cycle upon loss of TSC2 is dependent on the activity of the G1 cyclin-dependent kinases (CDKs), Cdk2 or Cdk4. Taken together with our finding that antisense inhibition of TSC2 causes up-regulation of cyclin D1 expression, these results provide the first evidence for a connection between tuberin/Rap1 and the G1 CDK-dependent regulation of the transition from G0/G1 to S phase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361010     DOI: 10.1074/jbc.272.46.29301

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 3.  Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway.

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak; Tomasz Grzela; Maciej Lazarczyk
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Jaime M C Gard; Raymond B Nagle; Justin D Dietrich; Terrence J Monks; Serrine S Lau
Journal:  Toxicol Sci       Date:  2011-08-02       Impact factor: 4.849

5.  Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.

Authors:  T Soucek; R S Yeung; M Hengstschläger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Tuberin--a new molecular target in Alzheimer's disease?

Authors:  Rosa Ferrando-Miguel; Margit Rosner; Angelika Freilinger; Gert Lubec; Markus Hengstschläger
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

Review 7.  New insights into the tumor suppression function of P27(kip1)

Authors:  B E Clurman; P Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

8.  Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.

Authors:  Fang Fang; Shaogang Sun; Li Wang; Jun-Lin Guan; Marco Giovannini; Yuan Zhu; Fei Liu
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

Review 9.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

10.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.